Simon Williams Pharma Consulting (Swpc) LLC

Pharmaceutical Consulting Firm.

Based in NJ

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $90K in lobbying spend across 8 quarterly filings, Simon Williams Pharma Consulting (Swpc) LLC is an active lobbying client. Their lobbying covers 1 issue area. Active from 2020 to 2021.

$90K
Total Spend
2
Years Active
1
Firms Hired
3
Lobbyists Deployed
1
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2020$60K
2021$30K

Issues Lobbied

MED

Lobbying Firms

Faegre Drinker Biddle & Reath LLP

Lobbyists

Ilisa Halpern PaulJodie CurtisLaura Hanen

Government Agencies Targeted

These are the government entities that Simon Williams Pharma Consulting (Swpc) LLC disclosed contacting in their lobbying filings.

Defense, Dept of (DOD)HOUSE OF REPRESENTATIVESSENATE
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: MED

Pandemic Preparedness

Pandemic preparedness.

Pandemic preparedness; Medical device federal contracts.

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?

Related Investigations

Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

Kessler Foundation
$980K total spend
Mt Pharma America, INC.
$800K total spend
National Association of Pediatric Nurse Practitioners
$766K total spend
Glaxosmithkline Consumer Healthcare Holdings (US) LLC DBA Haleon
$620K total spend
Wcg Clinical, INC.
$540K total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.